NanoPin Technologies Inc. services

NanoPin assays can detect extremely low levels of active disease elements (antigen peptides) in blood samples.  This is a critical differentiator with other diagnostic assays which can not distinguish between latent and active disease.

NanoPin`s technology can readily detect infectious disease in a wide range of patient populations.  In the example of tuberculosis, our technology is able to accurate detect TB in not only adult populations but also chidren and infants and immunocomprised patient group such as those with HIV co-infection.

NanoPin has proprietary intellectual property for its diagnostic platform, methods, and applications.  We are committed to enhancing our IP as we work with our partners to provide advanced diagnostic assays in the USA and globally. 

Our sensitive and accurate diagnostic platform is capable of detecting both known diseases such as TB and HIV and can be a future rapid response platform for future contagions.  The platform can be adapted to future disease markers in blood for novel disease applications.